Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a video call replace In-Person therapy for stroke recovery?

NCT ID NCT07661849

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a home-based telerehabilitation program (Tele-CPASS) to standard in-person therapy for improving arm and hand function after a stroke. Forty-two recent stroke survivors with arm weakness will be randomly assigned to receive 20 hours of either remote or in-person therapy focused on daily activities. Researchers will measure arm function before, right after, and at 6 and 12 months to see if the remote option works as well.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
telerehabilitation program (Tele-CPASS)
What this could lead to
If successful, this could provide a convenient, home-based therapy option that helps stroke survivors regain arm and hand function without needing to travel to a clinic.
What could go wrong
This is a small, early-stage study with only 42 participants, so results may not apply to everyone. The remote format may not be as effective as in-person therapy for some individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Aug 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 21 years or older * Neuroimaging-confirmed stroke within 40 days prior to enrollment * Persistent hemiparesis resulting in impaired upper extremity function, defined by a score of 0 to 3 on the NIH Stroke Scale motor arm item * Able to participate in all study-related activities, including 1-year follow-up * Short Blessed Memory Orientation and Concentration Scale score less than 8 * Able to follow 2-step commands * Montreal Cognitive Assessment (MoCA) score greater than 25 * No upper extremity injury or condition that limited upper extremity use prior to the stroke Exclusion Criteria: * Inability to provide informed consent * Persistent disabling neurologic condition, such as multiple sclerosis, Parkinsonism, amyotrophic lateral sclerosis, or dementia requiring medication * Clinically significant fluctuations in mental status within 72 hours prior to randomization * Active psychosis, psychosis within the prior 2 years, active substance abuse, or prior substance abuse * Dense sensory loss, defined by a score of 3 or 4 on the NIH Stroke Scale sensory item * Ataxia out of proportion to weakness in the affected arm, defined by a score greater than 1 on the NIH Stroke Scale ataxia item * Not expected to survive 12 months because of other illnesses * Pregnancy * Severe aphasia * Receipt of botulinum toxin or expectation of receiving botulinum toxin during the study period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiparesis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Rehabilitation Sciences Complex, University of Texas at El Paso, 3333 N Mesa St, El Paso, TX 79902

    RECRUITING

    El Paso, Texas, 79902, United States

  • Texas Tech University Health Sciences Center El Paso - Neurology Clinic

    RECRUITING

    El Paso, Texas, 79905, United States

  • University Medical Center of El Paso - Rehabilitation Services

    RECRUITING

    El Paso, Texas, 79905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.